Zydus Therapeutics Inc.
Clinical trials sponsored by Zydus Therapeutics Inc., explained in plain language.
-
HIV liver disease drug trial halted early
Disease control TerminatedThis study aimed to test if a drug called saroglitazar magnesium could reduce liver fat in people living with HIV who also have fatty liver disease (NAFLD). It was a Phase 2 trial that planned to compare the drug against a placebo using MRI scans to measure liver fat. The study w…
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Drug trial aims to shrink dangerous liver fat in women with common hormone disorder
Disease control TerminatedThis study tested whether a drug called saroglitazar could reduce the amount of fat in the liver for women who have both polycystic ovary syndrome (PCOS) and fatty liver disease. About 60 women were randomly assigned to receive either the real drug or a placebo pill for 24 weeks.…
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC